CHROMOPIC SENSING PRIVATE LIMITED

Cover Block

PUBLIC

Field	Value
Name	CHROMOPIC SENSING PRIVATE LIMITED
Tagline	Develops application-specific photonic integrated chips (ASPICs) for OEMs in healthcare, navigation, and quantum technologies [YourStory, January 2024] [Inc42, January 2024]
Headquarters	Gulbarga, India [Falcon Ebiz, retrieved 2026]
Founded	2024 [Falcon Ebiz, retrieved 2026] [YourStory, January 2024]
Stage	Pre-Seed [YourStory, January 2024]
Business Model	B2B [Chromopic, retrieved 2026]
Industry	Deeptech [Inc42, January 2024]
Technology Type	Hardware [Inc42, January 2024]
Geography	South Asia [Falcon Ebiz, retrieved 2026]
Growth Profile	Venture Scale [Inc42, January 2024]
Founding Team	Solo Founder [Inc42, January 2024]
Funding Label	Undisclosed [Inc42, January 2024]

Links

Public sources

• Website: https://www.chromopic.com/
• X / Twitter: https://x.com/adityapatil

Executive Summary

PUBLIC ChromoPIC Sensing Private Limited is a January 2024 Indian photonic-chip startup developing application-specific photonic integrated chips for OEM use cases in healthcare, navigation, and quantum technologies, and it merits investor attention because the company is targeting component-level integration in categories where smaller form factors and system reliability can matter materially if the technology proves out [Inc42, January 2024] [YourStory, January 2024] [Tracxn, 2025]. The public record is still thin, but incorporation timing, a disclosed early funding event, and continued exhibitor presence in 2026 suggest a company that is early, active, and still in technology-building mode rather than one making scaled commercial claims [Inc42, January 2024] [SES India, 2026] [BSX India, September 2026].

The product story is more specific than many pre-seed hardware profiles: ChromoPIC describes "Light Engine Platforms, on a Chip," with stated application areas spanning solid-state gyroscopes and IMUs, spectroscopy and microfluidic interfaces for medical devices, and middleware modules for quantum systems [Chromopic, retrieved 2026] [Tracxn, 2025]. The differentiating claim is not a finished end-user instrument but the integration and miniaturization of photonic sensing and light-engine components into chips that OEMs can embed, which is a credible strategic wedge if the company can demonstrate manufacturability and design wins [Chromopic, retrieved 2026] [YourStory, January 2024].

Leadership appears centered on founder and CEO Aditya Pralhad Patil, whom public sources identify as the sole founder, with company materials also listing Georgy Thomas in operations and several advisors [Inc42, January 2024] [Prometheus Foundation, retrieved 2026] [X/@adityapatil, retrieved 2026]. Patil's public profile points to an engineering and writing background rather than an already well-documented semiconductor commercialization track record, so the near-term investment question is less about ambition and more about whether the team can translate technical positioning into repeatable OEM engagement [Prometheus Foundation, retrieved 2026] [Medium/@adityapatil24680, retrieved 2026].

On capital, Inc42 reports one undisclosed January 2024 seed or early-stage round backed by Semiconductor Fabless Accelerator Lab, while Tracxn lists authorized share capital of ₹10 lakh and paid-up capital of ₹1.18 lakh, figures that are directionally useful but not a proxy for operating runway [Inc42, January 2024] [Tracxn, 2026]. The model is clearly B2B and OEM-facing; over the next 12 to 18 months, the public milestones worth watching are evidence of named design partners or customers, proof that the product stack has moved beyond positioning into validated deployments, and signs that headcount, financing, or partnerships are expanding in step with the technical scope [Chromopic, retrieved 2026] [Synapse, November 2025] [SES India, 2026].

Company-stated, unverified -- Core company, funding, and product facts are supported by Inc42, YourStory, Tracxn, and the company website, but several team and product details remain company-side or thinly corroborated.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Deeptech
Technology Type	Hardware
Geography	South Asia
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	Undisclosed

How the Company Got Here

PUBLIC

ChromoPIC Sensing Private Limited appears to be a very early photonics company built around a narrow technical claim rather than a broad commercial story. Public records indicate the company is based in Gulbarga, India, and incorporated in January 2024 as a private limited entity, while Crunchbase classifies it as a hardware-focused startup developing photonic chip technology [Crunchbase] [thecompanycheck.com, 2024].

The legal and capitalization trail is still thin, which is typical at this stage but worth stating plainly. Corporate-profile databases list the entity as CHROMOPIC SENSING PRIVATE LIMITED, with Tracxn reporting authorized share capital of ₹10 lakh and paid-up capital of ₹1.18 lakh as of its 2026 legal-entity profile [Tracxn, 2026]. The company website describes its product direction as "Light Engine Platforms, on a Chip," positioning the business around application-specific photonic integrated chips for OEM use cases rather than end-user devices [Chromopic, retrieved 2026].

The clearest public milestone after incorporation is financing, though the details remain limited. Inc42 records one funding event dated January 2024 from Semiconductor Fabless Accelerator Lab, with the amount undisclosed, and Crunchbase also lists the company with early-stage funding activity but without a disclosed round size [Inc42, January 2024] [Crunchbase]. That sequence, incorporation followed almost immediately by accelerator-backed seed support, suggests the company entered the market with external sponsorship in place, but the public record does not yet establish customer traction, manufacturing progress, or additional rounds [Inc42, January 2024] [Chromopic, retrieved 2026].

Lightly corroborated -- Company formation and profile details are corroborated by Crunchbase and a company-record database, but several operating details rely on company materials and a single funding database entry.

Product and Technology

MIXED Product scope and technical positioning

The product claim is straightforward, even if the underlying evidence base is still thin. ChromoPIC says it develops application-specific photonic integrated chips, or ASPICs, for OEMs in healthcare, navigation, and quantum technologies, and describes the offering on its website as "Light Engine Platforms, on a Chip" [Chromopic, retrieved 2026] [YourStory, January 2024] [Tracxn, 2025]. Public descriptions point to a component supplier model rather than a finished-device brand, with the stated value proposition centered on integrating and miniaturizing photonic sensing and light-engine functions onto chips that can be embedded into downstream systems [Chromopic, retrieved 2026] [Tracxn, 2025].

The application set is broad for a company incorporated in January 2024, which makes the distinction between target use cases and verified deployments important. Public materials reference solid-state gyroscopes and IMUs for navigation, spectroscopy and labeled or label-free detection for medical devices, microfluidic interfaces, and middleware modules for quantum applications [Chromopic, retrieved 2026] [Tracxn, 2025]. Those statements establish technical intent and category focus, but the available public record does not show a verified demo, named commercial customer, or published performance benchmark for any of these product surfaces [Chromopic, retrieved 2026] [SES India, 2026] [BSX India, September 2026].

MIXED Evidence of maturity and current limitations

The most credible public read is that ChromoPIC is positioning itself at the intersection of photonics miniaturization and OEM integration, a useful wedge if it can shorten development cycles for system builders in sensing-heavy markets [Chromopic, retrieved 2026] [YourStory, January 2024]. That is a technically ambitious place to start. It also means investors should separate architecture claims from proof points, because exhibitor listings and startup database profiles confirm visibility and categorization, not field reliability, manufacturability, or procurement traction [SES India, 2026] [BSX India, September 2026] [Inc42, January 2024].

The company’s public materials also suggest a cross-border presence, with operations or presence cited in Bangalore, Toronto, and Sunnyvale, but those references do not by themselves establish engineering depth or commercial footprint in each location [Chromopic, retrieved 2026]. With no surfaced job postings and fewer than 10 employees according to Synapse, the practical implication is that ChromoPIC’s technical scope may currently be ahead of its publicly visible operating scale [Synapse, November 2025]. That does not invalidate the thesis, but it does keep the section in an early, evidence-limited category.

Company-stated, unverified -- Product descriptions rely primarily on company materials and startup databases, with limited independent public corroboration and no verified public demo or benchmark in the sources used.

Where the Demand Sits

PUBLIC

Photonic sensing matters now because defense, healthcare instrumentation, and quantum-adjacent hardware are all pushing for smaller, lower-power, higher-reliability components, and that is the lane ChromoPIC says it intends to serve [Chromopic, retrieved 2026] [Tracxn, 2025].

The public record here is thin on direct market sizing for application-specific photonic integrated chips, so the cleanest approach is to frame the company against adjacent markets rather than assert a false precision. ChromoPIC positions its chips for navigation, medical devices, and quantum technologies [Chromopic, retrieved 2026] [Tracxn, 2025]. Those end markets are large in absolute terms, but no cited third-party report in the source set quantifies the photonic-chip slice that would translate into a credible TAM, SAM, or SOM for this company. That limitation matters because the commercial question is not whether navigation or healthcare are large, but whether OEMs will buy custom photonic subsystems at a pace that supports venture-scale outcomes.

A narrower read is still possible from the application mix the company itself names. In navigation, the stated focus on solid-state gyroscopes and IMUs suggests exposure to defense, aerospace, robotics, and autonomous systems procurement cycles rather than consumer electronics volume dynamics [Chromopic, retrieved 2026] [Tracxn, 2025]. In healthcare, the references to spectroscopy, labeled and label-free detection, and microfluidic interfaces point toward medical and diagnostic instrumentation, where qualification and integration timelines are typically long but switching costs can be meaningful if a component is designed into an OEM platform [Chromopic, retrieved 2026]. Quantum is earlier and less concrete, with ChromoPIC describing "plug-and-play middleware modules" rather than a disclosed production deployment base [Chromopic, retrieved 2026] [Tracxn, 2025].

The visible demand drivers are therefore more qualitative than numerical. One is system miniaturization: ChromoPIC's stated differentiation is integrating light-engine and sensing functions onto chips for OEM integration, which aligns with broader industry demand for smaller form factors and reduced system complexity [Chromopic, retrieved 2026]. Another is reliability at the component level, especially in navigation and medical settings where calibration, repeatability, and power budgets can matter more than headline software features [Chromopic, retrieved 2026]. A third is supply-chain localization and strategic hardware interest in India, which is indirectly supported by the company's backing from Semiconductor Fabless Accelerator Lab and its presence in 2026 industry exhibition circuits tied to defense and electronics [Inc42, January 2024] [SES India, 2026] [BSX India, September 2026]. Event participation does not prove demand, but it does place the company in sectors where sovereign capability and specialized component sourcing are receiving attention.

Regulatory and macro forces cut both ways. Medical-device pathways can create durable barriers once a component is qualified, but they also slow sales cycles and raise validation burdens [Chromopic, retrieved 2026]. Defense and aerospace applications can support premium technical requirements, yet they usually depend on long procurement calendars and compliance work that young hardware teams must absorb before revenue scales materially [SES India, 2026]. Quantum-related demand remains the least mature of the three wedges, which makes it better viewed as option value than near-term commercial certainty based on the current public evidence [Chromopic, retrieved 2026] [Tracxn, 2025].

Market lens	What the sources support	Source basis
Navigation components	Exposure to solid-state gyroscopes and IMUs as target applications	[Chromopic, retrieved 2026] [Tracxn, 2025]
Healthcare instrumentation	Exposure to spectroscopy, labeled or label-free detection, and microfluidic interfaces for medical devices	[Chromopic, retrieved 2026]
Quantum tooling	Exposure to middleware modules for quantum applications, with maturity still unclear from public evidence	[Chromopic, retrieved 2026] [Tracxn, 2025]
India strategic electronics ecosystem	Evidence of investor and exhibitor presence in semiconductor and defense-adjacent channels, not yet proof of scaled commercial adoption	[Inc42, January 2024] [SES India, 2026] [BSX India, September 2026]

The table shows a market story built from end-use exposure rather than measured category share. For investors, that makes the next diligence step straightforward: validate which of these three wedges is producing the fastest design-in momentum, because the public record does not yet establish a dominant beachhead.

Company-stated, unverified -- Market framing relies materially on company-described applications and positioning, with limited independent corroboration from Tracxn, Inc42, and exhibitor listings.

Competitive Landscape

MIXED ChromoPIC appears to be positioning itself less as a finished instrumentation vendor and more as a component supplier for OEMs that need photonic sensing functions compressed onto custom chips, which places it in a different lane from many better-known device and platform companies in healthcare, navigation, and quantum systems [Chromopic, retrieved 2026] [Inc42, January 2024] [Tracxn, 2025].

The public record is thin on named direct rivals, but the segmentation is still legible from the company’s own product claims. In navigation, ChromoPIC says it is developing chip-scale components for solid-state gyroscopes and IMUs, a field that spans incumbent inertial-sensing suppliers and newer photonics-based approaches [Chromopic, retrieved 2026] [Tracxn, 2025]. In healthcare, its stated focus on spectroscopy, labeled and label-free detection, and microfluidic interfaces points toward competition with diagnostic-instrument makers and sensing-module suppliers rather than drug developers or care providers [Chromopic, retrieved 2026]. In quantum, the company’s description of plug-and-play middleware modules suggests adjacency to quantum-enablement hardware and control-stack vendors, although no named public competitor is established in the source set [Chromopic, retrieved 2026].

That matters because ChromoPIC’s competitive claim is really about architecture. The company is presenting ASPICs and "Light Engine Platforms, on a Chip" as an integration path for technology OEMs, research labs, startups, corporations, and government agencies, rather than as standalone lab equipment [Chromopic, retrieved 2026]. If that description holds in practice, the edge is miniaturization and OEM embedability. It is a credible wedge for customers that value size, weight, power, and system-level integration, particularly in navigation and electro-optic sensing. The durability of that edge is less certain, because there is no public evidence yet of proprietary manufacturing scale, named design wins, patent position, or distribution control that would make the moat look hard to replicate [Chromopic, retrieved 2026] [Inc42, January 2024].

The company is most exposed where customer qualification cycles are long and incumbents already own trusted channels. A small team, reported as fewer than 10 employees, can be an advantage for speed, but it also suggests limited bandwidth across productization, applications engineering, regulatory support, and field deployment at the same time [Synapse, November 2025]. That is especially relevant in medical-device and navigation supply chains, where OEM adoption often turns on validation history and manufacturing reliability rather than only technical novelty. Semiconductor Fabless Accelerator Lab is the only publicly cited backer, and the disclosed funding remains undisclosed in size, which leaves open questions about how much capital ChromoPIC can commit to qualification-heavy programs compared with better-capitalized hardware peers [Inc42, January 2024].

The most plausible 18-month scenario is a selective rather than broad competitive outcome. If OEMs in defense-adjacent navigation or electro-optic sensing prioritize compact custom integration, ChromoPIC could be a winner if its chip-level approach converts exhibitor visibility and early technical discussions into one or two reference engagements, especially given its 2026 presence in industry events such as SES and BSX [SES India, 2026] [BSX India, September 2026]. The loser if that does not happen is not necessarily a named external rival from the current source base, but ChromoPIC itself: absent public evidence of customer adoption, the company risks being outcompeted by incumbent subsystem vendors and adjacent instrumentation suppliers that already control procurement relationships. On the evidence available publicly, the competitive picture is promising at the concept level and still unproven at the channel level.

Company-stated, unverified -- This section relies primarily on company website product positioning, supplemented by Inc42, Tracxn, Synapse, and exhibitor listings; the source set includes no independently verified named competitor list or public customer-win evidence.

Opportunity

PUBLIC

The prize here is straightforward: if ChromoPIC can turn photonic sensing from a system-level integration project into an application-specific chip sold into OEM products, it could occupy a valuable control point in markets where smaller form factor, lower power draw, and tighter sensor integration matter at the device level [Chromopic, retrieved 2026] [Inc42, January 2024] [Tracxn, 2025].

The headline opportunity is not that ChromoPIC becomes a broad photonics conglomerate. It is that the company becomes a specialist supplier of application-specific photonic integrated chips for a narrow set of high-value use cases, then expands account by account from design partnership to embedded component status inside customer hardware [Chromopic, retrieved 2026] [Tracxn, 2025]. That outcome is still early and lightly evidenced, but it is at least reachable on public facts because the company is positioning around OEM integration rather than direct end-customer hardware sales, and because its stated application areas, navigation, medical-device sensing, and quantum middleware, are all categories where component miniaturization can matter materially to system performance and manufacturability [Chromopic, retrieved 2026] [YourStory, January 2024].

The plausible paths to scale are best thought of as a few distinct bets rather than one linear plan.

Scenario	What happens	Catalyst	Why it's plausible
Navigation component supplier	ChromoPIC wins one or more OEM design-ins for chip-scale photonic sensing modules used in solid-state gyroscopes or IMUs, then expands within the same accounts across product lines	A successful validation cycle with a navigation or aerospace-oriented customer, followed by inclusion in a production bill of materials [Chromopic, retrieved 2026] [SES India, 2026]	The company explicitly names solid-state gyroscopes and IMUs as target applications, and its 2026 presence at defence and electronics exhibitions is at least consistent with an effort to reach buyers in that ecosystem [Chromopic, retrieved 2026] [SES India, 2026] [BSX India, September 2026]
Medtech sensing platform	ChromoPIC supplies photonic chip components for spectroscopy, labeled or label-free detection, and microfluidic interfaces that medical-device OEMs integrate into compact instruments	A development partnership with a device maker that needs smaller optical subsystems and lower integration complexity [Chromopic, retrieved 2026]	The company already frames healthcare OEMs as a target buyer set and describes specific sensing functions rather than a generic platform pitch, which suggests a more concrete product wedge than a pure research-services model [Chromopic, retrieved 2026] [Inc42, January 2024]
Quantum enablement layer	ChromoPIC's "plug-and-play middleware modules" become a useful photonic building block for quantum equipment makers that want subsystem suppliers rather than fully custom internal development	A category partner, lab program, or startup customer validates the module approach and shortens time to integration for subsequent buyers [Chromopic, retrieved 2026]	The claim is still company-led, but the positioning toward middleware modules for quantum applications implies a supply-layer role that can scale if customers prefer specialized vendors over fully bespoke builds [Chromopic, retrieved 2026] [Tracxn, 2025]

The compounding mechanism, if it appears, would come from design-in economics rather than consumer-style network effects. A component company like this can improve its position as each successful program produces reference architectures, validation data, packaging know-how, and a clearer path to manufacturing support for the next OEM account; the more often an engineering team can say "this subsystem already fits a similar use case," the lower the integration friction becomes [Chromopic, retrieved 2026]. Public evidence that this flywheel has started is still thin, and that matters. The useful signal is simply that the company is presenting itself as an OEM-facing chip supplier across multiple application families and showing up in industry venues where system buyers congregate, which is at least consistent with an early design-partner motion [Chromopic, retrieved 2026] [SES India, 2026] [BSX India, September 2026].

The size of the win is difficult to quantify from public data because there is no confirmed market-sizing dataset in the available materials and no disclosed revenue base to anchor scenario math. The cleaner way to frame it is strategic rather than numeric: if ChromoPIC becomes an embedded supplier for even one demanding category such as navigation or medical-device optics, the company could move from a small pre-seed hardware startup to a scarce photonics asset with acquisition appeal to larger semiconductor, sensing, or instrumentation incumbents (scenario, not a forecast) [Inc42, January 2024] [Tracxn, 2025]. The public record supports upside as a component-platform story, not yet as a scale story. That is still enough to make the opportunity noteworthy at this stage.

Company-stated, unverified -- This section relies heavily on company descriptions and startup database profiles, with limited independent corroboration beyond funding and exhibitor listings [Chromopic, retrieved 2026] [Inc42, January 2024] [SES India, 2026].

Sources

Public sources

1. [YourStory, January 2024] ChromoPIC Sensing Company Profile Funding & Investors | https://yourstory.com/companies/chromopic-sensing

2. [Inc42, January 2024] ChromoPIC Key People 2026 - Founders, CEO & CXOs | https://inc42.com/company/chromopic/people/

3. [Falcon Ebiz, retrieved 2026] CHROMOPIC SENSING PRIVATE LIMITED HAVING CIN U26109KA2024PTC183049 IS 1 YEARS, 8 MONTHS & 24 DAYS OLD PRIVATE COMPANY | https://www.falconebiz.com/company/CHROMOPIC-SENSING-PRIVATE-LIMITED-U26109KA2024PTC183049

4. [Chromopic, retrieved 2026] Home | Chromopic | https://www.chromopic.com/

5. [Prometheus Foundation, retrieved 2026] Aditya Patil | Prometheus Foundation Grantee | https://prometheusfdn.org/grantees/aditya-patil/

6. [X/@adityapatil, retrieved 2026] Aditya Patil (@adityapatil) on X | https://x.com/adityapatil

7. [Medium/@adityapatil24680, retrieved 2026] On Cillian Murphy. Notes for me, written here for living a… | https://medium.com/@adityapatil24680/on-cillian-murphy-2b17b857fae7

8. [Tracxn, 2026] CHROMOPIC SENSING PRIVATE LIMITED - 2026 Company Profile & Financials - Tracxn | https://tracxn.com/d/legal-entities/india/chromopic-sensing-private-limited/__JwCJgMtDh360OWWrNYu1hqNMzIGFcSi9pxhIj2FU10U

9. [SES India, 2026] Exhibit at SES 2026 | https://ses-india.in/exhibition.html

10. [BSX India, September 2026] BSX 2026 - List of Exhibitors | https://bsxindia.com/assets/img-2026/pdf/BSX%202026%20-%20List%20of%20Exhibitors%2005-09-2026..pdf

11. [Crunchbase] ChromoPIC - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/chromopic

12. [thecompanycheck.com, 2024] ChromoPIC Sensing Private Limited - FY 2025 Insights | https://www.thecompanycheck.com/company/chromopic-sensing-private-limited/U26109KA2024PTC183049

13. [Tracxn, 2025] ChromoPIC - Provider of solid state gyroscopes, IMUs, and quantum middleware modules | https://tracxn.com/d/companies/chromopic/__Nx3EmWxhlUgCnuztFASuJ-etM4UOGVyX4L4oZXThL6A

14. [Synapse, November 2025] ChromPIC Sensing Pvt Ltd. - Drug pipelines, Patents, Clinical trials - Synapse | https://synapse.patsnap.com/organization/edac4150bc672c3f0fc2c6cb0d2d7d7a